-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On April 7th, Livzon Pharmaceutical issued an announcement stating that the company and its wholly-owned subsidiary Livzon Microspheres have recently received the approval of triptorelin pamoate microspheres for injection from the State Food and Drug Administration.
After 6 years of research and development, triptorelin pamoate microspheres for injection is a high-end long-acting microsphere preparation independently developed by Livzon Pharmaceutical.
The announcement shows that this product is a gonadotropin releasing hormone agonist injected intramuscularly every three months, and is indicated for the treatment of locally advanced or metastatic prostate cancer.